The Klinique Med Stock Shares Owned By Institutions
| KLINIQ Stock | 31.75 1.00 3.05% |
The Klinique Med fundamentals help investors to digest information that contributes to Klinique Med's financial success or failures. It also enables traders to predict the movement of Klinique Stock. The fundamental analysis module provides a way to measure Klinique Med's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Klinique Med stock.
Klinique |
The Klinique Med Company Shares Owned By Institutions Analysis
Klinique Med's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 0.0% of The Klinique Med are shares owned by institutions. This is 100.0% lower than that of the Consumer Cyclical sector and 100.0% lower than that of the Personal Services industry. The shares owned by institutions for all Thailand stocks is 100.0% higher than that of the company.
Klinique Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Klinique Med's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Klinique Med could also be used in its relative valuation, which is a method of valuing Klinique Med by comparing valuation metrics of similar companies.Klinique Med is currently under evaluation in shares owned by institutions category among its peers.
Klinique Fundamentals
| Return On Equity | 0.95 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 9.44 B | |||
| Shares Outstanding | 220 M | |||
| Shares Owned By Insiders | 73.66 % | |||
| Price To Book | 39.18 X | |||
| Price To Sales | 5.73 X | |||
| Revenue | 1.49 B | |||
| Gross Profit | 558.77 M | |||
| EBITDA | 288.81 M | |||
| Book Value Per Share | 0.95 X | |||
| Earnings Per Share | 1.09 X | |||
| Target Price | 44.5 | |||
| Market Capitalization | 7.81 B | |||
| Last Dividend Paid | 0.43 |
About Klinique Med Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze The Klinique Med's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klinique Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The Klinique Med based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Klinique Stock
Klinique Med financial ratios help investors to determine whether Klinique Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Klinique with respect to the benefits of owning Klinique Med security.